UV GermiFRA:1NY 72 EBITDA Margin % is -3.65% as of Dec. 2025. GuruFocus rates FRA:1NY with a GF Score™ of 72/100 and a GF Value™ of €3.40. The stock has 2 warning signs investors should review. Among 3,032 Industrial Products companies, UV Germi ranks worse than 62.04% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. UV Germi's EBITDA for the
six
months ended in Dec. 2025 was €-0.12 Mil. UV Germi's Revenue for the
six
months ended in Dec. 2025 was €3.17 Mil. Therefore, UV Germi's EBITDA margin for the quarter that ended in Dec. 2025 was -3.65%.
UV Germi (FRA:1NY) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
UV Germi EBITDA Margin % Related Terms
UV Germi EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for UV Germi's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1NY vs VLTO, ZWS, CECO: EBITDA Margin % Comparison
For the Pollution & Treatment Controls subindustry, UV Germi's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UV Germi EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, UV Germi's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where UV Germi's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UV Germi (FRA:1NY) has a EBITDA Margin % of -3.65% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UV Germi and its competitors. According to the industry distribution chart, UV Germi ranks #1881 out of 3032 companies in the Industrial Products industry, placing it in the top 62%.
Is UV Germi's EBITDA Margin % too high?
UV Germi's current EBITDA Margin % is -3.65%. Based on the distribution chart, UV Germi ranks #1881 out of 3032 companies in the Industrial Products industry, which is below the industry midpoint. Overall, UV Germi has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does UV Germi's EBITDA Margin % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, UV Germi ranks #1881 out of 3032 companies for EBITDA Margin %. This places UV Germi in the lower half of its industry. The industry median EBITDA Margin % is 9.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.46, based on 3,032 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UV Germi and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UV Germi's current EBITDA Margin % is -3.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UV Germi stock overvalued right now?
UV Germi (FRA:1NY) has a current EBITDA Margin % of -3.65%. The stock's GF Value™ is €3.40, compared to a current price of €2.23 — trading 34.4% below its estimated fair value. The current EBITDA Margin % is -3.65%. UV Germi's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For UV Germi (FRA:1NY), the current EBITDA Margin % is -3.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UV Germi (FRA:1NY) Overvalued in 2026?
Based on GuruFocus' analysis, UV Germi stock appears to be undervalued.
The current stock price of €2.23 is trading 34.4% below its estimated GF Value™ of €3.40.
Key valuation signals for FRA:1NY:
EBITDA Margin %: -3.65%
GF Value™: €3.40 vs. price of €2.23 (34.4% below fair value)
No single metric tells the full story. See the FRA:1NY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1NY has been successfully added to your 
